Home / Companies / Catalyst Pharmaceuticals, Inc. / 22 Aug 2023
Catalyst Pharmaceuticals, Inc.: meeting of 22 Aug 2023
Votes reported on Form N-PX, item by item
387 Form N-PX filers reported votes at the Catalyst Pharmaceuticals, Inc. meeting of 22 Aug 2023. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
7 nominees; 95.4% of reported votes for; 28 filers withheld from or voted against at least one nominee.
2,058 vote records from 151 filers. 6 of the 151 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
648 vote records from 379 filers. 28 of the 366 filers that marked the item either way voted against management. 13 filers reported this item without a management mark.
4 filers reported share counts too large to be the holding described. No share split is published for this item. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
293 vote records from 150 filers. 1 of the 150 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
318 vote records from 155 filers. 7 of the 155 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
266 vote records from 136 filers. 134 of the 136 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
28 vote records from 17 filers. 13 of the 17 filers that marked the item either way voted against management.
Several categoriesSecurity holder
Shareholder proposals (not separable from the filings)
Filers described these proposals in wordings that could not be matched to one another, so they are shown together.
1 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Catalyst Pharmaceuticals, Inc. meeting?
387 Form N-PX filers reported votes at the meeting of 22 Aug 2023. On say-on-pay, 28 of 366 voted against management (7.7%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Catalyst Pharmaceuticals, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Catalyst Pharmaceuticals, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Catalyst Pharmaceuticals, Inc. with a meeting date within three days of 22 Aug 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.